Vigilant Capital Management, LLC - BIO-TECHNE CORP ownership

BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 556 filers reported holding BIO-TECHNE CORP in Q3 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

About BIO-TECHNE CORP

Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.

Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.

In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.

Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.

Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Vigilant Capital Management, LLC ownership history of BIO-TECHNE CORP
ValueSharesWeighting
Q4 2022$4
-99.9%
48
+300.0%
0.00%
Q3 2022$3,000
-25.0%
120.0%0.00%
Q2 2022$4,000
-20.0%
120.0%0.00%
Q1 2022$5,000
-16.7%
120.0%0.00%
Q4 2021$6,0000.0%120.0%0.00%
Q3 2021$6,000120.00%
Other shareholders
BIO-TECHNE CORP shareholders Q3 2021
NameSharesValueWeighting ↓
ROWLANDMILLER & PARTNERS.ADV 47,975$3,701,7510.85%
Diversified Trust Co 13,882$1,071,1350.04%
Czech National Bank 27,698$2,137,1780.03%
FULTON BANK, N.A. 5,444$420,0580.02%
DnB Asset Management AS 27,637$2,132,4710.01%
Versant Capital Management, Inc 36$2,7780.00%
MASSMUTUAL TRUST CO FSB/ADV 371$28,6260.00%
Bartlett & Co. LLC 172$130.00%
View complete list of BIO-TECHNE CORP shareholders